According to Adverum Biotechnologies
's latest financial reports the company has HK$1.19 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | HK$1.45 B | -39.07% |
2021-12-31 | HK$2.37 B | -28.57% |
2020-12-31 | HK$3.33 B | 157.62% |
2019-12-31 | HK$1.29 B | -19.48% |
2018-12-31 | HK$1.60 B | 7.91% |
2017-12-31 | HK$1.48 B | -13.62% |
2016-12-31 | HK$1.72 B | -14.2% |
2015-12-31 | HK$2.00 B | 62.41% |
2014-12-31 | HK$1.23 B | 28170.85% |
2013-12-31 | HK$4.37 M | 58.05% |
2012-12-31 | HK$2.76 M |